This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goodin, S. Articles by DiPaola, R. S. Search for Related Content PubMed PubMed Citation Articles by Goodin, S. Articles by DiPaola, R. S. Related Collections Clinical Intervention Clinical Intervention: Diet and Diet-related Factors Clinical Intervention: Biomarkers Clinical Intervention: Early-Phase (I/II) Clinical or Translational Trials

Clinical and Biological Activity of Soy Protein Powder Supplementation in Healthy Male Volunteers

Departments of ¹ Medicine and ² Pediatrics, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, ³ The Cancer Institute of New Jersey, and ⁴ The Dean and Betty Gallo Prostate Cancer Center, New Brunswick, New Jersey; and ⁵ Ernest Mario School of Pharmacy, Pharmaceutical Industry Fellowship Institute, Rutgers, The State University of New Jersey, and ⁶ Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey

Requests for reprints: Susan Goodin, The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, 195 Little Albany Street, New Brunswick, NJ 08903-2681. Phone: 732-235-7472; Fax: 732-235-7493. E-mail: goodin{at}umdnj.edu

Purpose: To determine if a commonly used soy protein supplement exhibits biological activity in vivo and in vitro, we evaluated an over-the-counter soy protein powder supplement using blood from healthy male volunteers and in an estrogen receptor in vitro assay.

Subjects and Methods: We recruited healthy male volunteers 18 years of age or older that were in good health. Treatment consisted of consuming two scoops (56 g) of pure soy protein powder (Puritan's Pride, Oakdale, NY) daily for 28 days. Serum testosterone and luteinizing hormone (LH) levels were collected on days –7, 0, 14, and 28 of therapy, and day 42. A reporter estrogen receptor (ER) assay was used to determine the effect on ER-ß and ER- in vitro.

Results: Twelve subjects were enrolled with a mean age of 32.25 years (range 25 to 47). Serum testosterone decreased 19%(±22%) during the 4-week use of soy protein powder (P = 0.021) and increased within 2 weeks after we discontinued soy protein powder. Serum LH concentrations decreased during the 4-week use of soy protein powder then increased within 2 weeks after we stopped the soy protein powder, but the changes did not reach statistical significance (P = 0.20). Soy protein powder was found to induce agonist activity to ER-ß using a reporter estrogen receptor assay in yeast.

Conclusion: Soy protein powder decreases serum testosterone levels in healthy men and acts as an ER-ß agonist; the significance of this biological effect with respect to cancer prevention needs further study. (Cancer Epidemiol Biomarkers Prev 2007;16(4):829–33)

This article has been cited by other articles:

				M. Messina, J. Hamilton-Reeves, M. Kurzer, and W. Phipps Effect of Soy Protein on Testosterone Levels Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2795 - 2795. [Full Text] [PDF]

				S. Goodin, W. J. Shih, M. Gallo, J. Aisner, and R. S. DiPaola Effect of Soy Protein on Testosterone Levels Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2796 - 2796. [Full Text] [PDF]